EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver Cirrhosis

Katja Dinkelborg iD, Christian Niehaus iD, Birgit Bremer, Christine Wundes, Anja Tiede, Natalie Petruch, Katja Deterding, Anke R M Kraft, Björn Hartleben, Markus Cornberg iD, Heiner Wedemeyer iD, Patrick Behrendt iD und 1 weitere

Liver International · 2026

DOI: 10.1111/liv.70727 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Liver International, 2026. Verfasst von Katja Dinkelborg und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Hepatitis E, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum für Infektionsforschung, German Ministry of Education and Research, Medizinischen Hochschule Hannover.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Hepatitis E virus (HEV) infection is very frequent in Europe with more than 2 million annual infections. Patients with liver cirrhosis may face an increased risk of suffering from acute‐on‐chronic liver failure (ACLF) due to HEV infection. We explored the consequences and prevalence of HEV infection in individuals with liver cirrhosis.

Methods

We retrospectively analysed the clinical outcome of all consecutive patients who were hospitalized at our center due to acute HEV infection and analysed their outcome between 2014 and 2024. Next, we tested 249 sera from 184 cirrhotic patients during individual episodes of acute hepatic decompensation for anti‐HEV IgM and HEV‐RNA to analyse the relevance of acute HEV infection as a triggering event. Finally, we established a single center cohort of patients with advanced liver cirrhosis, and assessed the anti‐HEV IgG seroprevalence ( n = 332).

Results

Over the past decade, 32 patients with liver cirrhosis who were hospitalized due to acute HEV infection were identified. Among these patients, 16 (50%) developed ACLF, resulting in five fatalities (31.3%) and three individuals (18.8%) requiring liver transplantation for survival. Of 249 sera obtained during acute hepatic decompensation, 11 (4.4%) were either HEV‐RNA positive ( n = 2) and/or anti‐HEV IgM positive ( n = 10), linking HEV infection to these acute decompensations. Screening of patients with liver cirrhosis for anti‐HEV IgG showed that 67.2% of patients (223/332) were anti‐HEV negative and thus at potential risk for future HEV infection.

Conclusions

Patients with advanced liver cirrhosis are at risk of acute HEV infection, which is a relevant cause of hepatic decompensation and ACLF with high mortality in these patients. Trial Registration: DRKS00010664; NCT04801290

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute-On-Chronic Liver FailureHepatitis ELiver CirrhosisAdultAgedFemaleHumansMaleMiddle AgedAcute DiseaseHepatitis AntibodiesHepatitis E virusImmunoglobulin GImmunoglobulin MLiver TransplantationPrevalenceRetrospective StudiesRNA, ViralSeroepidemiologic Studies

Stichwörter der Autor:innen

ACLFHEVliver cirrhosisseroprevalence

Substanzen

Hepatitis AntibodiesImmunoglobulin GImmunoglobulin MRNA, Viral

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
  • TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany.
  • German Center for Infectious Disease Research (DZIF), Partner Sites Hannover-Braunschweig, Braunschweig, Germany.
  • Centre for Individualised Infection Medicine (CiiM), a Joint Venture Between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), Hannover, Germany.
  • Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.

ORCID-Profile: Katja Dinkelborg, Christian Niehaus, Markus Cornberg, Heiner Wedemeyer, Patrick Behrendt, Benjamin Maasoumy

Förderung

  • Deutsches Zentrum für Infektionsforschung
  • German Ministry of Education and Research
  • Medizinischen Hochschule Hannover

Zitieren

APA

Dinkelborg, K., Niehaus, C., Bremer, B., Wundes, C., Tiede, A., Petruch, N., Deterding, K., Kraft, A. R. M., Hartleben, B., Cornberg, M., Wedemeyer, H., Behrendt, P., & Maasoumy, B. (2026). Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver Cirrhosis. Liver International. https://doi.org/10.1111/liv.70727

Vancouver

Dinkelborg K, Niehaus C, Bremer B, Wundes C, Tiede A, Petruch N, et al. Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver Cirrhosis. Liver International. 2026. doi:10.1111/liv.70727

BibTeX
@article{Dinkelborg2026,
  author = {Dinkelborg, Katja and Niehaus, Christian and Bremer, Birgit and Wundes, Christine and Tiede, Anja and Petruch, Natalie and Deterding, Katja and Kraft, Anke R M and Hartleben, Björn and Cornberg, Markus and Wedemeyer, Heiner and Behrendt, Patrick and Maasoumy, Benjamin},
  title = {Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver Cirrhosis},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70727}
}
Kostenlos starten →